2021
DOI: 10.1097/med.0000000000000680
|View full text |Cite
|
Sign up to set email alerts
|

Nonprescribed androgen use among women and trans men

Abstract: Purpose of review To summarize the most recent evidence regarding nonprescribed androgen use among women and trans men. Recent findings Fourteen heterogeneous studies met inclusion criteria. Three provided lifetime prevalence estimates among particular subgroups (from 0.5 to 8%), whereas one longitudinal study found adverse childhood experiences predicted later nonprescribed androgen use. Mental health and substance problems appear to correlate with sev… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 61 publications
0
1
0
Order By: Relevance
“…diminish threat-based negative attitudes toward statistically less frequent variations in sexual orientation and gender identity as well as EBAGH-driven stereotypes of cisgender men. Lastly, reminiscent of AAS users (see Kimergård, 2015), some members of the transgender community self-treat with nonprescribed hormones (Havnes & Muller, 2021;Rotondi et al, 2013) and/or offer peer-to-peer guidance born out of dissatisfaction with the content and framing of relevant information available through medical sources (Bosom & Medico, 2021). EBAGH-congruent conceptualizations of testosterone in such contexts could have adverse consequences: For example, Castañeda (2020) observed that some Filipino transgender men who videorecorded their experiences appeared euphoric before their first testosterone dose, but given an "expectation of being gendered as male after T, the tolerance for misgendering is lowered," which could trigger "relapse to dysphoria since their masculinity is even further questioned despite testosterone" (p. 14).…”
Section: Intervention Implicationsmentioning
confidence: 99%
“…diminish threat-based negative attitudes toward statistically less frequent variations in sexual orientation and gender identity as well as EBAGH-driven stereotypes of cisgender men. Lastly, reminiscent of AAS users (see Kimergård, 2015), some members of the transgender community self-treat with nonprescribed hormones (Havnes & Muller, 2021;Rotondi et al, 2013) and/or offer peer-to-peer guidance born out of dissatisfaction with the content and framing of relevant information available through medical sources (Bosom & Medico, 2021). EBAGH-congruent conceptualizations of testosterone in such contexts could have adverse consequences: For example, Castañeda (2020) observed that some Filipino transgender men who videorecorded their experiences appeared euphoric before their first testosterone dose, but given an "expectation of being gendered as male after T, the tolerance for misgendering is lowered," which could trigger "relapse to dysphoria since their masculinity is even further questioned despite testosterone" (p. 14).…”
Section: Intervention Implicationsmentioning
confidence: 99%